Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45

United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.84M

$873.65K on a plan · $0.00 straight out of an exercise

Sold at will

$964.83K

2 of 7 sales

Net

−$1.84M

−$964.83K against sales at will